Skip to content

Type: Posters

In Silico Assessment of Variation in TMB Quantification Across Diagnostic Platforms: Phase 1 of the Friends of Cancer Research Harmonization Project

TMB Standardization by Alignment to Reference Standards

Collaborative Meta-analytical Approaches to Advance the Use of ctDNA in Clinical Cancer Research: The Friends of Cancer Research ctMoniTR Project

Assessing Variability Across HRD Assays: Findings from the Friends’ HRD Harmonization Project

AACR 2023 Poster Presentation: Findings from the Friends of Cancer Research HRD Harmonization Project

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

Changes in ctDNA levels as an early indicator of outcomes in advanced NSCLC treated with TKI: Initial findings from a retrospective aggregate analysis of 8 clinical trials

Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.

Background: The onset of the COVID-19 pandemic resulted in major disruptions in enrollment and conduct of cancer clinical trials. In response, regulators allowed modifications to traditional trial processes to enable clinical research and care to continue. The American Society of Clinical Oncology and Friends of Cancer Research established a task force to evaluate how sponsors…